EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Targets for Pediatric Pulmonary Vein Stenosis: Insights from Animal Models

Siqi She, Debao Li, Qi Sun, Lincai Ye iD

Children · 14.05.2026 · 13 (5) · 677

DOI: 10.3390/children13050677 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Children, online erschienen am 14.05.2026. Verfasst von Siqi She und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute for Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shan…. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary vein stenosis (PVS) is a rare and devastating condition affecting infants and children, characterized by progressive intimal hyperplasia, myofibroblast proliferation, and extracellular matrix deposition, leading to pulmonary hypertension and right heart failure. Despite multimodal interventions including surgery and catheter-based approaches, long-term outcomes remain poor due to high rates of restenosis and disease progression. The development of representative animal models has been instrumental in unraveling the complex pathophysiology of PVS and identifying potential therapeutic targets. This review comprehensively examines the evolution of PVS animal models—from large animals to recently established rodent models—and synthesizes insights gained regarding key pathogenic pathways and their therapeutic implications in guiding associated clinical trials in pediatric patients. We discuss evidence supporting mammalian target of rapamycin (mTOR) inhibition, TGF-β, platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) targeting, and emerging strategies including fibroblast activation protein (FAP) inhibition and YAP/β-catenin pathway modulation. The recent development of neonatal rat PVS models has accelerated translational research by enabling cost-effective, high-throughput evaluation of candidate therapies. We propose a mechanistic framework integrating these pathways and discuss future directions for precision medicine approaches in PVS.

Schlagwörter

Stichwörter der Autor:innen

animal modelslosartanmyofibroblastspulmonary vein stenosissirolimustherapeutic targetstranslational research

Autor:innen und Institutionen

  • Shanghai Institute for Pediatric Congenital Heart Disease, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • Department of Pediatric Surgery, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China.
  • Department of Thoracic and Cardiovascular Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.
  • Institute of Pediatric Translational Medicine, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China.

ORCID-Profile: Lincai Ye

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

She, S., Li, D., Sun, Q., & Ye, L. (2026). Therapeutic Targets for Pediatric Pulmonary Vein Stenosis: Insights from Animal Models. Children, 13(5), 677. https://doi.org/10.3390/children13050677

Vancouver

She S, Li D, Sun Q, Ye L. Therapeutic Targets for Pediatric Pulmonary Vein Stenosis: Insights from Animal Models. Children. 2026;13(5):677. doi:10.3390/children13050677

BibTeX
@article{She2026,
  author = {She, Siqi and Li, Debao and Sun, Qi and Ye, Lincai},
  title = {Therapeutic Targets for Pediatric Pulmonary Vein Stenosis: Insights from Animal Models},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {5},
  pages = {677},
  doi = {10.3390/children13050677}
}
Kostenlos starten →